$heff's $tation of $tocks & $olid DD

[06mets]

sheff, as far as ANX now is the time, ANX is trading at cash value, tax selling is all but over, vinerolbine results will be out soon(company is very optimistic on the results), insiders are loading up down here, and despite the cofactor phase 2b findings which didnt meet expectations(they are still pursuing cofactor for breast cancer), they are actively pursuing a partnership with a big pharma and they have a robust pipeline of drugs wwhich they r very high on, plus carl icahn is one of the largest shareholders, .47 is ridiculous for this stock, i see it going to a buck quick, keep in mind it was 5.40 not to long ago, if your looking for a nice quick gainer ANX is the play imo